NAYA Biosciences Corp - NAYA Operatsion marja

NAYA Biosciences (NAYA) kompaniyasining korporativ logotipi

Monoklonal dori vositalari tadqiqotlarining erta bosqichlari tufayli tijorat daromadlarining yo'qligi NAYA Biosciences (NAYA) o'sishini tadqiqot va ishlanmalar (R&D) xarajatlari sohasiga ko'chiradi. Operatsion foyda marjasi ushbu xususiyatni aks ettiradi, bunda -90.90 eng so'nggi qiymatni ifodalaydi. Biznes barqarorligi innovatsion bioplatformalar va AQShdagi birlashishlarga tayanadi, garchi sinovlarning muvaffaqiyatsizligi xavflari va spekulyativ investitsiyalarga to'liq bog'liqlik saqlanib qolgan bo'lsa-da.

NAYA: NAYA Biosciences Inc. Operatsion faoliyat rentabelligi 04.07.2022 - 28.04.2025

NAYA (NAYA Biosciences): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

Kompaniyaning har tomonlama tahlili:NAYA Biosciences Corp, NAYA
NAYA Biosciences Corp asosiy tovari

Biologlar shtati va klinik sinovlarga investitsiya kiritadigan NAYA Biosciences uchun operatsion marja tadqiqot va ishlanmalar (R&D) xarajatlarini boshqarish samaradorligining ko'rsatkichi bo'lib xizmat qiladi. EBIT marjasini tahlil qilish soliqlardan va foizlardan oldingi operatsion foyda ulushini baholash imkonini beradi hamda qarz yuklamasi va bir martalik bozor tebranishlarining ta'sirini istisno qilgan holda, innovatsion biznes model resurslarni qanchalik muvaffaqiyatli daromadga aylantirishini ko'rsatadi.

Raqobatchilar tahlili

Operatsion rentabellik BeiGene Ltd|Halozyme Therapeutics - Operatsion foyda marjasi|Sotuvning operatsion marjasi RVMD (Revolution Medicines Corp)|Operatsion foyda koeffitsiyenti AAPG|Operatsion rentabellik CG Oncology Therapeutics CGON|Operatsion foyda normasi URGN|BCAX: Sotuvning operatsion marjasi|PSNL: Operatsion rentabellik|Erasca (ERAS) - Operatsion rentabellik|DCTH - Operatsion faoliyat rentabelligi|YMAB (Y-mAbs Corp) - Operatsion marja|Sotuvning operatsion marjasi Aura Biosciences (AURA)|Operatsion rentabellik Candel Therapeutics Inc. (CADL)|Sotuvning operatsion marjasi Accuray, Inc. ARAY|Operatsion rentabellik sellaslifesciences.com SLS|Operatsion foyda normasi ACTU|CTOR - Operatsion rentabellik|Operatsion faoliyat rentabelligi tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Operatsion rentabellik|FATE: Operatsion foyda koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Operatsion marja|TCRX (TScan Therapeutics) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Champions Oncology (CSBR)|Operatsion faoliyat rentabelligi XBiotech USA|Operatsion rentabellik CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Sotuvning operatsion rentabelligi|RADX - Operatsion rentabellik|ARTV - Operatsion marja|Adlai Nortye Ltd (ANL) - Operatsion rentabellik|Veru Pharma - Operatsion foyda normasi|Operatsion rentabellik Tempest Therapeutics Corp|Operatsion foyda bo'yicha sotuv rentabelligi XLO (Xilio Therapeutics, Inc.)|Operatsion marja RENB|MURA (Mural Oncology) - Operatsion foyda normasi|Operatsion marja KAPA (Kairos Pharma Ltd)|OKUR: Operatsion foyda bo'yicha sotuv rentabelligi|GDTC: Sotuvning operatsion marjasi|CRIS - Operatsion marja|APLM: Operatsion marja|Sotuvning operatsion rentabelligi tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Operatsion marja|Operatsion marja Genprex Inc.|Operatsion marja CLDI|Sotuvning operatsion marjasi Sunshine Biopharma, Inc. SBFM|Operatsion marja XBIO (Xenetic Biosciences)|Operatsion foyda normasi SLRX|PPBT - Operatsion rentabellik|AONC (aoncology.com) - Operatsion foyda bo'yicha sotuv rentabelligi|BGNE: Operatsion marja|Checkpoint Therapeutics Inc (CKPT) - Operatsion marja|ELEV (Elevation Oncology Inc.) - Operatsion marja|icadmed.com (ICAD) - Operatsion faoliyat rentabelligi|Operatsion marja IKNA|NTBL (Notable Labs) - Operatsion foyda normasi|Operatsion marja VIRX (Viracta Therapeutics)|Operatsion faoliyat rentabelligi MorphoSys AG (MOR)|Ascentage Pharma Group International - Operatsion marja